The World Health Organization has elevated the risk of the Bundibugyo strain of Ebola in the Democratic Republic of Congo to 'very high' nationally, declaring it an emergency of international concern. This particular strain of Ebola currently lacks an approved vaccine or treatment, with the WHO also assessing the risk as 'high' regionally and 'low' globally.
Current Situation
The Democratic Republic of Congo has reported 82 confirmed cases and 7 confirmed deaths, alongside nearly 750 suspected cases. Uganda has seen two cases linked to travel from the DRC, one of which was fatal. The outbreak has prompted international attention, with Britain pledging up to £20 million to support containment efforts in both the DRC and Uganda.
Response and Treatment
An experimental oral COVID antiviral drug, Obeldesivir, is being considered for use among Ebola contacts to prevent disease development, though under strict protocols. The WHO continues to monitor the situation closely, coordinating with national health authorities to implement control measures.
The declaration of a global emergency underscores the seriousness of the outbreak, particularly given the lack of approved vaccines or treatments for the Bundibugyo strain. International collaboration is deemed critical to prevent further spread and mitigate the impact on affected communities.
